JAK Inhibitor Promising for Polymyalgia Rheumatica

(MedPage Today) -- Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term corticosteroids.
Among 14 patients in...